Literatures

Primary Site >> Stomach Cancer

Gene >> CD274

1.
Journal:	World J Gastroenterol. 2003 Jun;9(6):1370-3.
Title:	In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma.
Author:	Chen, Xiao-Li\|Cao, Xu-Dong\|Kang, An-Jing\|Wang, Kang-Min\|Su, Bao-Shan\|Wang, Yi-Li
PMID:	12800259

2.
Journal:	Acta Histochem. 2006;108(1):19-24.
Title:	Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.
Author:	Wu, Changping\|Zhu, Yibei\|Jiang, Jingting\|Zhao, Jiemin\|Zhang, Xue-Guang\|Xu, Ning
PMID:	16530813

3.
Journal:	Tissue Antigens. 2007 Jan;69(1):19-27.
Title:	PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies.
Author:	Sun, J\|Xu, K\|Wu, C\|Wang, Y\|Hu, Y\|Zhu, Y\|Chen, Y\|Shi, Q\|Yu, G\|Zhang, X
PMID:	17212704

4.
Journal:	Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):192-5.
Title:	[Expression and significance of B7-H1 and its receptor PD-1 in human gastric carcinoma].
Author:	Liu, Shu-Man\|Meng, Qing\|Zhang, Qin-Xian\|Wang, Sheng-Dian\|Liu, Zhan-Ju\|Zhang, Xie-Fu
PMID:	18756934

5.
Journal:	Immunol Res. 2011 Aug;50(2-3):269-75.
Title:	T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
Author:	Lu, Binfeng\|Chen, Lujun\|Liu, Lin\|Zhu, Yibei\|Wu, Changping\|Jiang, Jingting\|Zhang, Xueguang
PMID:	21717068

6.
Journal:	Yonago Acta Med. 2011 Mar;54(1):1-10. Epub 2011 Mar 1.
Title:	Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer.
Author:	Matsunaga, Tomoyuki\|Saito, Hiroaki\|Ikeguchi, Masahide
PMID:	24031123

7.
Journal:	Hum Mutat. 2012 Mar;33(3):480-4.
Title:	A frequent somatic mutation in CD274 3'-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding.
Author:	Wang, Weipeng\|Sun, Jing\|Li, Fang\|Li, Rui\|Gu, Yongping\|Liu, Cuiping\|Yang, Peng\|Zhu, Ming\|Chen, Lujun\|Tian, Wenyan\|Zhou, Huan\|Mao, Yong\|Zhang, Liang\|Jiang, Jingting\|Wu, Changping\|Hua, Dong\|Chen, Weichang\|Lu, Binfeng\|Ju, Jingfang\|Zhang, Xueguang
PMID:	22190470

8.
Journal:	N Engl J Med. 2012 Jun 28;366(26):2455-65.
Title:	Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Author:	Brahmer, Julie R\|Tykodi, Scott S\|Chow, Laura Q M\|Hwu, Wen-Jen\|Topalian, Suzanne L\|Hwu, Patrick\|Drake, Charles G\|Camacho, Luis H\|Kauh, John\|Odunsi, Kunle\|Pitot, Henry C\|Hamid, Omid\|Bhatia, Shailender\|Martins, Renato\|Eaton, Keith\|Chen, Shuming\|Salay, Theres
PMID:	22658128

9.
Journal:	Chin J Cancer Res. 2014 Feb;26(1):104-11.
Title:	Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications.
Author:	Zheng, Zhixue\|Bu, Zhaode\|Liu, Xijuan\|Zhang, Lianhai\|Li, Ziyu\|Wu, Aiwen\|Wu, Xiaojiang\|Cheng, Xiaojing\|Xing, Xiaofang\|Du, Hong\|Wang, Xiaohong\|Hu, Ying\|Ji, Jiafu
PMID:	24653632

10.
Journal:	Exp Mol Pathol. 2014 Jun;96(3):284-91.
Title:	Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer.
Author:	Hou, Jingying\|Yu, Zhong\|Xiang, Rengyun\|Li, Chuqiang\|Wang, Lin\|Chen, Shufen\|Li, Qingyun\|Chen, Mei\|Wang, Linyun
PMID:	24657498

11.
Journal:	Nature. 2014 Sep 11;513(7517):202-9.
Title:	Comprehensive molecular characterization of gastric adenocarcinoma.
Author:
PMID:	25079317

12.
Journal:	Med Oncol. 2014 Nov;31(11):268.
Title:	The role of B7-H1 in gastric carcinoma: clinical significance and related mechanism.
Author:	Jiang, Dong\|Xu, Yun-yun\|Li, Fang\|Xu, Biao\|Zhang, Xue-guang
PMID:	25311064

13.
Journal:	Int J Clin Exp Pathol. 2014 Aug 15;7(9):6015-23. eCollection 2014.
Title:	B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer.
Author:	Chen, Lujun\|Deng, Haifeng\|Lu, Mingyang\|Xu, Bin\|Wang, Qi\|Jiang, Jingting\|Wu, Changping
PMID:	25337246

14.
Journal:	Int J Clin Oncol. 2015 Apr;20(2):273-81.
Title:	Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
Author:	Geng, Yiting\|Wang, Hui\|Lu, Changqing\|Li, Qing\|Xu, Bin\|Jiang, Jingting\|Wu, Changping
PMID:	24804867

15.
Journal:	Exp Mol Med. 2015 Jan 23;47:e134.
Title:	Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.
Author:	Gulley, Margaret L
PMID:	25613731

16.
Journal:	Int J Oncol. 2015 Apr;46(4):1421-34.
Title:	Update on Epstein-Barr virus and gastric cancer (review).
Author:	Shinozaki-Ushiku, Aya\|Kunita, Akiko\|Fukayama, Masashi
PMID:	25633561

17.
Journal:	Drug Des Devel Ther. 2015 Feb 16;9:901-9.
Title:	Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer.
Author:	Qing, Yi\|Li, Qing\|Ren, Tao\|Xia, Wei\|Peng, Yu\|Liu, Gao-Lei\|Luo, Hao\|Yang, Yu-Xin\|Dai, Xiao-Yan\|Zhou, Shu-Feng\|Wang, Dong
PMID:	25733810

18.
Journal:	Oncol Lett. 2015 Apr;9(4):1833-1838.
Title:	B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor.
Author:	Yang, Yupeng\|Wu, K E\|Zhao, Ende\|Li, Wei\|Shi, Liang\|Xie, Gengchen\|Jiang, Bin\|Wang, Yaxin\|Li, Ruidong\|Zhang, Peng\|Shuai, Xiaoming\|Wang, Guobin\|Tao, Kaixiong
PMID:	25789052

19.
Journal:	Curr Treat Options Oncol. 2015 Apr;16(4):17.
Title:	Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Author:	Sunakawa, Yu\|Lenz, Heinz-Josef
PMID:	25813036

20.
Journal:	J Immunother. 2015 Jun;38(5):167-84.
Title:	Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity.
Author:	Xiao, Weiming\|Wu, Keyan\|Yin, Min\|Han, Sen\|Ding, Yanbing\|Qiao, Ahui\|Lu, Guotao\|Deng, Bing\|Bo, Ping\|Gong, Weijuan
PMID:	25962106

21.
Journal:	PLoS One. 2015 Jun 26;10(6):e0131403.
Title:	PD-L1 and Survival in Solid Tumors: A Meta-Analysis.
Author:	Wu, Pin\|Wu, Dang\|Li, Lijun\|Chai, Ying\|Huang, Jian
PMID:	26114883

22.
Journal:	Gigascience. 2015 Aug 6;4:37.
Title:	Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing.
Author:	Hou, Yong\|Wu, Kui\|Shi, Xulian\|Li, Fuqiang\|Song, Luting\|Wu, Hanjie\|Dean, Michael\|Li, Guibo\|Tsang, Shirley\|Jiang, Runze\|Zhang, Xiaolong\|Li, Bo\|Liu, Geng\|Bedekar, Niharika\|Lu, Na\|Xie, Guoyun\|Liang, Han\|Chang, Liao\|Wang, Ting\|Chen, Jianghao\|Li, Yingrui\|Zhang,
PMID:	26251698

23.
Journal:	Pathobiology. 2015;82(5):212-23.
Title:	Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
Author:	Abe, Hiroyuki\|Kaneda, Atsushi\|Fukayama, Masashi
PMID:	26337667

24.
Journal:	J Gastrointest Oncol. 2015 Oct;6(5):561-9.
Title:	Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations.
Author:	Raufi, Alexander G\|Klempner, Samuel J
PMID:	26487950

25.
Journal:	Medicine (Baltimore). 2015 Oct;94(43):e1911.
Title:	Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in Gastric Cancer: A Systematic Review and Meta-Analysis.
Author:	Xu, Feng\|Feng, Guosheng\|Zhao, Hongwei\|Liu, Fuquan\|Xu, Lingling\|Wang, Qian\|An, Guangyu
PMID:	26512615

26.
Journal:	Int J Clin Exp Pathol. 2015 Sep 1;8(9):11084-91. eCollection 2015.
Title:	Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Author:	Zhang, Lin\|Qiu, Miaozhen\|Jin, Ying\|Ji, Jiao\|Li, Baoxia\|Wang, Xueping\|Yan, Shumei\|Xu, Ruihua\|Yang, Dajun
PMID:	26617827

27.
Journal:	Tumour Biol. 2016 Jun;37(6):7327-32.
Title:	The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography.
Author:	Wang, Lin-Ang\|Wei, Xi\|Li, Qing\|Chen, Lin
PMID:	26671554

28.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Feb;19(2):225-32.
Title:	[Progression of immunotherapy in gastric cancer].
Author:	Wei, Xiaoli\|Xu, Ruihua
PMID:	26831889

29.
Journal:	J Gastrointest Cancer. 2016 Jun;47(2):125-34.
Title:	Advances of Molecular Targeted Therapy in Gastric Cancer.
Author:	Cetin, Bulent\|Gumusay, Ozge\|Cengiz, Mustafa\|Ozet, Ahmet
PMID:	26875080

30.
Journal:	Target Oncol. 2016 Aug;11(4):469-77.
Title:	Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
Author:	Alsina, Maria\|Moehler, Markus\|Hierro, Cinta\|Guardeno, Raquel\|Tabernero, Josep
PMID:	26880697

31.
Journal:	Hum Pathol. 2016 Jul;53:25-34.
Title:	Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Author:	Dong, Min\|Wang, Hai-Yan\|Zhao, Xiao-Xiao\|Chen, Jian-Ning\|Zhang, Yi-Wang\|Huang, Yan\|Xue, Ling\|Li, Hai-Gang\|Du, Hong\|Wu, Xiang-Yuan\|Shao, Chun-Kui
PMID:	26980034

32.
Journal:	Eur J Cancer. 2016 May;59:160-170.
Title:	Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
Author:	Moehler, Markus\|Delic, Maike\|Goepfert, Katrin\|Aust, Daniela\|Grabsch, Heike I\|Halama, Niels\|Heinrich, Bernd\|Julie, Catherine\|Lordick, Florian\|Lutz, Manfred P\|Mauer, Murielle\|Alsina Maqueda, Maria\|Schild, Hansjoerg\|Schimanski, Carl C\|Wagner, Anna-Dorothea\|R
PMID:	27039171

33.
Journal:	J Clin Oncol. 2016 Jul 20;34(21):2460-7.
Title:	Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
Author:	Nanda, Rita\|Chow, Laura Q M\|Dees, E Claire\|Berger, Raanan\|Gupta, Shilpa\|Geva, Ravit\|Pusztai, Lajos\|Pathiraja, Kumudu\|Aktan, Gursel\|Cheng, Jonathan D\|Karantza, Vassiliki\|Buisseret, Laurence
PMID:	27138582

34.
Journal:	Oncotarget. 2016 May 31;7(22):32925-32.
Title:	Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
Author:	Derks, Sarah\|Liao, Xiaoyun\|Chiaravalli, Anna M\|Xu, Xinsen\|Camargo, M Constanza\|Solcia, Enrico\|Sessa, Fausto\|Fleitas, Tania\|Freeman, Gordon J\|Rodig, Scott J\|Rabkin, Charles S\|Bass, Adam J
PMID:	27147580

35.
Journal:	Lancet Oncol. 2016 Jun;17(6):717-726.
Title:	Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.
Author:	Muro, Kei\|Chung, Hyun Cheol\|Shankaran, Veena\|Geva, Ravit\|Catenacci, Daniel\|Gupta, Shilpa\|Eder, Joseph Paul\|Golan, Talia\|Le, Dung T\|Burtness, Barbara\|McRee, Autumn J\|Lin, Chia-Chi\|Pathiraja, Kumudu\|Lunceford, Jared\|Emancipator, Kenneth\|Juco, Jonathan\|Koshi
PMID:	27157491

36.
Journal:	Oncotarget. 2016 Jun 28;7(26):39671-39679.
Title:	Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significance.
Author:	Yuan, Jiajia\|Zhang, Jie\|Zhu, Yan\|Li, Na\|Tian, Tiantian\|Li, Yang\|Li, Yanyan\|Li, Zhongwu\|Lai, Yumei\|Gao, Jing\|Shen, Lin
PMID:	27191996

37.
Journal:	World J Gastroenterol. 2016 May 21;22(19):4638-50.
Title:	Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Author:	Joo, Moon Kyung\|Park, Jong-Jae\|Chun, Hoon Jai
PMID:	27217696

38.
Journal:	Ann Surg Oncol. 2016 Oct;23(11):3684-3692.
Title:	Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis.
Author:	Kang, Hyo Jeong\|Lee, In-Seob\|Park, Young-Soo\|Ho, Won Jin\|Sohn, DaHye\|Ahn, Ji-Yong\|Yook, Jeong-Hwan\|Kim, Byung-Sik
PMID:	27221363

39.
Journal:	Onco Targets Ther. 2016 May 4;9:2649-54.
Title:	Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis.
Author:	Liu, Yong-Xuan\|Wang, Xin-Shuai\|Wang, Yu-Feng\|Hu, Xiao-Chen\|Yan, Jun-Qiang\|Zhang, Ya-Li\|Wang, Wei\|Yang, Rui-Jie\|Feng, Ying-Ying\|Gao, She-Gan\|Feng, Xiao-Shan
PMID:	27226727

40.
Journal:	Adv Exp Med Biol. 2016;917:95-120.
Title:	Therapeutic Antibodies in Cancer Therapy.
Author:	Gasser, Martin\|Waaga-Gasser, Ana Maria
PMID:	27236554

41.
Journal:	J Cancer Res Clin Oncol. 2016 Aug;142(8):1727-38.
Title:	Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
Author:	Takahashi, Naoki\|Iwasa, Satoru\|Sasaki, Yusuke\|Shoji, Hirokazu\|Honma, Yoshitaka\|Takashima, Atsuo\|Okita, Natsuko Tsuda\|Kato, Ken\|Hamaguchi, Tetsuya\|Yamada, Yasuhide
PMID:	27256004

42.
Journal:	Bull Cancer. 2016 Jul-Aug;103(7-8):643-50.
Title:	[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "a la carte" treatment?].
Author:	Dreyer, Chantal\|Afchain, Pauline\|Trouilloud, Isabelle\|Andre, Thierry
PMID:	27345450

43.
Journal:	Am J Surg Pathol. 2016 Nov;40(11):1496-1506.
Title:	Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
Author:	Ma, Changqing\|Patel, Krishna\|Singhi, Aatur D\|Ren, Bing\|Zhu, Benjamin\|Shaikh, Fyza\|Sun, Weijing
PMID:	27465786

44.
Journal:	World J Surg Oncol. 2016 Aug 11;14(1):212.
Title:	Gastric biomarkers: a global review.
Author:	Baniak, Nick\|Senger, Jenna-Lynn\|Ahmed, Shahid\|Kanthan, S C\|Kanthan, Rani
PMID:	27514667

45.
Journal:	Onco Targets Ther. 2016 Aug 12;9:5023-39.
Title:	PD-L1 expression in human cancers and its association with clinical outcomes.
Author:	Wang, Xin\|Teng, Feifei\|Kong, Li\|Yu, Jinming
PMID:	27574444

46.
Journal:	J Clin Med. 2016 Sep 22;5(10). pii: jcm5100084.
Title:	Immunotherapy for Gastroesophageal Cancer.
Author:	Goode, Emily F\|Smyth, Elizabeth C
PMID:	27669318

47.
Journal:	Mol Oncol. 2016 Dec;10(10):1551-1558.
Title:	Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.
Author:	Dai, Congqi\|Geng, Ruixuan\|Wang, Chenchen\|Wong, Angela\|Qing, Min\|Hu, Jianjun\|Sun, Yu\|Lo, A W I\|Li, Jin
PMID:	27720576

48.
Journal:	J Gastrointest Oncol. 2016 Oct;7(5):771-788.
Title:	The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1.
Author:	Jin, Zhaohui\|Yoon, Harry H
PMID:	27747091

49.
Journal:	Front Pharmacol. 2016 Oct 6;7:356.
Title:	Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention.
Author:	Nocera, Nadia F\|Lee, M Catherine\|De La Cruz, Lucy M\|Rosemblit, Cinthia\|Czerniecki, Brian J
PMID:	27766079

50.
Journal:	Therap Adv Gastroenterol. 2016 Nov;9(6):853-860.
Title:	Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.
Author:	Liu, Xiaojun\|Yang, Zhongxia\|Latchoumanin, Olivier\|Qiao, Liang
PMID:	27803740

51.
Journal:	J Clin Med. 2016 Nov 14;5(11). pii: jcm5110100.
Title:	The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma.
Author:	Shaib, Walid L\|Nammour, Jean Paul A\|Gill, Harpaul\|Mody, Mayur\|Saba, Nabil F
PMID:	27854242

52.
Journal:	Sci Rep. 2016 Nov 28;6:37933.
Title:	The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
Author:	Zhang, Minghui\|Dong, Yuandi\|Liu, Haitao\|Wang, Yan\|Zhao, Shu\|Xuan, Qijia\|Wang, Yan\|Zhang, Qingyuan
PMID:	27892511

53.
Journal:	Pharmacogenomics J. 2017 Dec;17(6):528-534.
Title:	Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.
Author:	Sunakawa, Y\|Cao, S\|Volz, N B\|Berger, M D\|Yang, D\|Parekh, A\|Zhang, W\|Matsusaka, S\|Ning, Y\|Stremitzer, S\|Stintzing, S\|Sebio, A\|Okazaki, S\|Wakatsuki, T\|Azuma, M\|Watanabe, M\|Koizumi, W\|Wu, A H\|Lenz, H-J
PMID:	27241062

54.
Journal:	Curr Cancer Drug Targets. 2017;17(6):534-554.
Title:	Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis.
Author:	Morales-Sanchez, Abigail\|Fuentes-Panana, Ezequiel M
PMID:	27677953

55.
Journal:	Cancer Immunol Immunother. 2017 Mar;66(3):309-318.
Title:	A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.
Author:	Tao, Li-Hua\|Zhou, Xin-Ru\|Li, Fu-Chao\|Chen, Qi\|Meng, Fan-Yi\|Mao, Yong\|Li, Rui\|Hua, Dong\|Zhang, Hong-Jian\|Wang, Wei-Peng\|Chen, Wei-Chang
PMID:	27889799

56.
Journal:	Mod Pathol. 2017 Mar;30(3):427-439.
Title:	Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.
Author:	Saito, Ruri\|Abe, Hiroyuki\|Kunita, Akiko\|Yamashita, Hiroharu\|Seto, Yasuyuki\|Fukayama, Masashi
PMID:	27934877

57.
Journal:	Biochem Biophys Res Commun. 2017 Mar 11;484(3):631-635.
Title:	Proteogenomic analysis of NCC-S1M, a gastric cancer stem cell-like cell line that responds to anti-PD-1.
Author:	Park, Jun Won\|Um, Hyejin\|Yang, Hanna\|Ko, Woori\|Kim, Dae-Yong\|Kim, Hark Kyun
PMID:	28153736

58.
Journal:	J Cancer Res Clin Oncol. 2017 May;143(5):883-894.
Title:	The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer.
Author:	Zhou, Zhi-Hua\|Ji, Cheng-Dong\|Zhu, Jiang\|Xiao, Hua-Liang\|Zhao, Hai-Bin\|Cui, You-Hong\|Bian, Xiu-Wu
PMID:	28180998

59.
Journal:	Ann Oncol. 2017 Aug 1;28(8):1767-1775.
Title:	New agents on the horizon in gastric cancer.
Author:	Lordick, F\|Shitara, K\|Janjigian, Y Y
PMID:	28184417

60.
Journal:	Medicine (Baltimore). 2017 Feb;96(7):e5730.
Title:	PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study.
Author:	Crescenzi, Anna\|Taffon, Chiara\|Donati, Michele\|Guarino, Michele Pier Luca\|Valeri, Sergio\|Coppola, Roberto
PMID:	28207501

61.
Journal:	Cell Physiol Biochem. 2017;41(3):907-920.
Title:	Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.
Author:	Li, Jing\|Chen, Lujun\|Xiong, Yuqi\|Zheng, Xiao\|Xie, Quanqin\|Zhou, Qi\|Shi, Liangrong\|Wu, Changping\|Jiang, Jingting\|Wang, Haitao
PMID:	28222426

62.
Journal:	Expert Rev Anticancer Ther. 2017 May;17(5):417-425.
Title:	Predictive biomarkers along gastric cancer pathogenetic pathways.
Author:	Panarese, Iacopo\|De Vita, Ferdinando\|Ronchi, Andrea\|Romano, Marco\|Alfano, Roberto\|Di Martino, Natale\|Zito Marino, Federica\|Ferraraccio, Francesca\|Franco, Renato
PMID:	28277834

63.
Journal:	Gut. 2017 Nov;66(11):1878-1880.
Title:	Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway.
Author:	Zhang, Xu\|Xu, Wenrong
PMID:	28348197

64.
Journal:	Expert Rev Clin Pharmacol. 2017 Jun;10(6):609-619.
Title:	Immunotherapy for gastric cancers: emerging role and future perspectives.
Author:	Bonotto, Marta\|Garattini, Silvio Ken\|Basile, Debora\|Ongaro, Elena\|Fanotto, Valentina\|Cattaneo, Monica\|Cortiula, Francesco\|Iacono, Donatella\|Cardellino, Giovanni Gerardo\|Pella, Nicoletta\|Fasola, Gianpiero\|Antonuzzo, Lorenzo\|Silvestris, Nicola\|Aprile, Giuse
PMID:	28349740

65.
Journal:	Oncoimmunology. 2017 Mar 10;6(3):e1267891.
Title:	Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.
Author:	Lopez-Albaitero, Andres\|Xu, Hong\|Guo, Hongfen\|Wang, Linlin\|Wu, Zhihao\|Tran, Hoa\|Chandarlapaty, Sarat\|Scaltriti, Maurizio\|Janjigian, Yelena\|de Stanchina, Elisa\|Cheung, Nai-Kong V
PMID:	28405494

66.
Journal:	Oncotarget. 2017 Apr 18;8(16):26356-26367.
Title:	Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Author:	Koh, Jiwon\|Ock, Chan-Young\|Kim, Jin Won\|Nam, Soo Kyung\|Kwak, Yoonjin\|Yun, Sumi\|Ahn, Sang-Hoon\|Park, Do Joong\|Kim, Hyung-Ho\|Kim, Woo Ho\|Lee, Hye Seung
PMID:	28412752

67.
Journal:	Oncotarget. 2017 Jun 13;8(24):38850-38862.
Title:	The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Author:	Jin, Shenying\|Xu, Bo\|Yu, Lixia\|Fu, Yao\|Wu, Hongyan\|Fan, Xiangshan\|Wei, Jia\|Liu, Baorui
PMID:	28418918

68.
Journal:	Oncotarget. 2017 Apr 25;8(17):28125-28134.
Title:	MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.
Author:	Wang, Yaxin\|Wang, Di\|Xie, Gengchen\|Yin, Yuping\|Zhao, Ende\|Tao, Kaixiong\|Li, Ruidong
PMID:	28427226

69.
Journal:	Medicine (Baltimore). 2017 May;96(18):e6369.
Title:	Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
Author:	Wang, Qianqian\|Liu, Fang\|Liu, Lei
PMID:	28471952

70.
Journal:	J Surg Res. 2017 May 1;211:30-38.
Title:	Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Author:	Hsu, Jun-Te\|Hsu, Chih-Sin\|Le, Puo-Hsien\|Chen, Tse-Ching\|Chou, Wen-Chi\|Lin, Chun-Yen\|Yeh, Ta-Sen
PMID:	28501128

71.
Journal:	Oncoimmunology. 2017 Feb 21;6(4):e1293215.
Title:	The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
Author:	Boger, Christine\|Behrens, Hans-Michael\|Kruger, Sandra\|Rocken, Christoph
PMID:	28507801

72.
Journal:	Cancer Immunol Immunother. 2017 Oct;66(10):1379-1381.
Title:	A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer.
Author:	Wang, Weili\|Liao, Ping\|He, Yijing
PMID:	28540431

73.
Journal:	Am Soc Clin Oncol Educ Book. 2017;37:292-300.
Title:	Immunotherapy for Esophageal and Gastric Cancer.
Author:	Kelly, Ronan J
PMID:	28561677

74.
Journal:	Cancer Immunol Res. 2017 Jul;5(7):524-534.
Title:	A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Author:	Wen, Ti\|Wang, Zhenning\|Li, Yi\|Li, Zhi\|Che, Xiaofang\|Fan, Yibo\|Wang, Shuo\|Qu, Jinglei\|Yang, Xianghong\|Hou, Kezuo\|Zhou, Wenyang\|Xu, Ling\|Li, Ce\|Wang, Jin\|Liu, Jing\|Chen, Liqun\|Zhang, Jingdong\|Qu, Xiujuan\|Liu, Yunpeng
PMID:	28619967

75.
Journal:	J Pathol. 2017 Oct;243(2):165-175.
Title:	Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.
Author:	Xing, Xiaofang\|Jia, Shuqin\|Wu, Jianmin\|Feng, Qin\|Dong, Bin\|Li, Bo\|Jia, Yongning\|Shan, Fei\|Li, Ying'ai\|Zhang, Yan\|Hu, Ying\|Wang, Xiaodong\|Liu, Xiangtao\|Yu, Weishi\|Zhang, Lianhai\|Bu, Zhaode\|Wu, Aiwen\|Li, Ziyu\|Ji, Jiafu
PMID:	28671728

76.
Journal:	Chin J Cancer. 2017 Jul 29;36(1):61.
Title:	Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
Author:	Gao, Yuan\|Li, Su\|Xu, Dazhi\|Chen, Shangxiang\|Cai, Yuchen\|Jiang, Wenqi\|Zhang, Xinke\|Sun, Jin\|Wang, Kefeng\|Chang, Boyang\|Wang, Fenghua\|Hong, Minghuang
PMID:	28754154

77.
Journal:	Gastrointest Cancer. 2017;7:1-11.
Title:	PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence.
Author:	Tran, Phu N\|Sarkissian, Sarmen\|Chao, Joseph\|Klempner, Samuel J
PMID:	28757801

78.
Journal:	Onco Targets Ther. 2017 Jul 21;10:3625-3634.
Title:	Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis.
Author:	Dai, Cong\|Wang, Meng\|Lu, Jun\|Dai, Zhiming\|Lin, Shuai\|Yang, Pengtao\|Tian, Tian\|Liu, Xinghan\|Min, Weili\|Dai, Zhijun
PMID:	28769571

79.
Journal:	J Cancer. 2017 Jun 3;8(9):1579-1585.
Title:	Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.
Author:	Fang, Wenfeng\|Chen, Ying\|Sheng, Jin\|Zhou, Ting\|Zhang, Yaxiong\|Zhan, Jianhua\|Liu, Lin\|Huang, Jiaxing\|Peng, Peijian\|Zhang, Li
PMID:	28775777

80.
Journal:	Biomed Res Int. 2017;2017:5791262.
Title:	Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.
Author:	Abozeid, Mohamed\|Rosato, Antonio\|Sommaggio, Roberta
PMID:	28781967

81.
Journal:	Int J Nanomedicine. 2017 Jul 26;12:5331-5343.
Title:	Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Author:	Luo, Xin\|Peng, Xia\|Hou, Jingying\|Wu, Shuyun\|Shen, Jun\|Wang, Lingyun
PMID:	28794626

82.
Journal:	PLoS One. 2017 Aug 10;12(8):e0182692.
Title:	PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
Author:	Gu, Lihu\|Chen, Manman\|Guo, Dongyu\|Zhu, Hepan\|Zhang, Wenchao\|Pan, Junhai\|Zhong, Xin\|Li, Xinlong\|Qian, Haoran\|Wang, Xianfa
PMID:	28796808

83.
Journal:	Oncology. 2017;93(6):387-394.
Title:	Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
Author:	Oki, Eiji\|Okano, Shinji\|Saeki, Hiroshi\|Umemoto, Yuichiro\|Teraishi, Koji\|Nakaji, Yu\|Ando, Koji\|Zaitsu, Yoko\|Yamashita, Nami\|Sugiyama, Masahiko\|Nakashima, Yuichiro\|Ohgaki, Kippei\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	28910818

84.
Journal:	Oncotarget. 2017 Jul 22;8(35):58887-58902.
Title:	Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.
Author:	Kim, Kyung-Ju\|Yang, Han Kwang\|Kim, Woo Ho\|Kang, Gyeong Hoon
PMID:	28938605

85.
Journal:	Oncotarget. 2017 May 16;8(40):67094-67103.
Title:	Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy.
Author:	Ma, Jing\|Li, Jianhui\|Hao, Yiming\|Nie, Yongzhan\|Li, Zengshan\|Qian, Meirui\|Liang, Qiaoyi\|Yu, Jun\|Zeng, Musheng\|Wu, Kaichun
PMID:	28978018

86.
Journal:	J Transl Med. 2017 Oct 12;15(1):206.
Title:	Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry.
Author:	Ying, Le\|Yan, Feng\|Meng, Qiaohong\|Yuan, Xiangliang\|Yu, Liang\|Williams, Bryan R G\|Chan, David W\|Shi, Liyun\|Tu, Yugang\|Ni, Peihua\|Wang, Xuefeng\|Xu, Dakang\|Hu, Yiqun
PMID:	29025424

87.
Journal:	Br J Cancer. 2017 Dec 5;117(12):1753-1760.
Title:	Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
Author:	Seo, An Na\|Kang, Byung Woog\|Kwon, Oh Kyoung\|Park, Ki Bum\|Lee, Seung Soo\|Chung, Ho Young\|Yu, Wansik\|Bae, Han Ik\|Jeon, Seong Woo\|Kang, Hyojeung\|Kim, Jong Gwang
PMID:	29073638

88.
Journal:	Biomed Res Int. 2017;2017:7869802.
Title:	Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Author:	Carlomagno, Nicola\|Incollingo, Paola\|Tammaro, Vincenzo\|Peluso, Gaia\|Rupealta, Niccolo\|Chiacchio, Gaetano\|Sandoval Sotelo, Maria Laura\|Minieri, Gianluca\|Pisani, Antonio\|Riccio, Eleonora\|Sabbatini, Massimo\|Bracale, Umberto Marcello\|Calogero, Armando\|Dodaro,
PMID:	29094049

89.
Journal:	BMC Med Genomics. 2017 Dec 6;10(1):74.
Title:	Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.
Author:	Budczies, Jan\|Denkert, Carsten\|Gyorffy, Balazs\|Schirmacher, Peter\|Stenzinger, Albrecht
PMID:	29212506

90.
Journal:	Klin Onkol. 2017 Winter;30(Supplementum3):50-54.
Title:	[Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors].
Author:	Obermannova, R
PMID:	29239193

91.
Journal:	Oncotarget. 2017 Oct 26;8(59):99372-99381.
Title:	Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.
Author:	Ju, Xiaoli\|Shen, Rong\|Huang, Pan\|Zhai, Jianhua\|Qian, Xiaobin\|Wang, Qiang\|Chen, Miao
PMID:	29245908

92.
Journal:	Sci Rep. 2017 Dec 19;7(1):17810.
Title:	IFNgamma induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.
Author:	Moon, Ji Wook\|Kong, Su-Kang\|Kim, Byung Soo\|Kim, Hyun Ji\|Lim, Hyangsoon\|Noh, Kyeonga\|Kim, Younghye\|Choi, Jung-Woo\|Lee, Ju-Han\|Kim, Young-Sik
PMID:	29259270

93.
Journal:	Cancer Biother Radiopharm. 2017 Dec;32(10):351-363.
Title:	Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma.
Author:	Curea, Fabiana G\|Hebbar, Mohamed\|Ilie, Silvia M\|Bacinschi, Xenia E\|Trifanescu, Oana G\|Botnariuc, Inga\|Anghel, Rodica M
PMID:	29265917

94.
Journal:	Klin Onkol. 2017 Winter;31(1):35-39.
Title:	[Current Status of Checkpoint Inhibitors in the Treatment of Esophageal and Gastric Tumors - Overview of Studies].
Author:	Vrana, David\|Matzenauer, Marcel\|Melichar, Bohuslav
PMID:	29488776

95.
Journal:	Ann Oncol. 2017 Jun 1;28(suppl_3). pii: 3916897.
Title:	LBA-009KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer.
Author:	Catenacci Daniel, V\|Wainberg, Zev\|Fuchs Charles, S\|Garrido, Marcelo\|Bang, Yung-Jue\|Muro, Kei\|Savage, Mary\|Wang, Jiangdian\|Koshiji, Minori\|Dalal Rita, P\|Kang, Yoon-Koo
PMID:	30052791

96.
Journal:	Cancer Sci. 2018 Jan;109(1):43-53.
Title:	PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
Author:	Mimura, Kousaku\|Teh, Jun Liang\|Okayama, Hirokazu\|Shiraishi, Kensuke\|Kua, Ley-Fang\|Koh, Vivien\|Smoot, Duane T\|Ashktorab, Hassan\|Oike, Takahiro\|Suzuki, Yoshiyuki\|Fazreen, Zul\|Asuncion, Bernadette R\|Shabbir, Asim\|Yong, Wei-Peng\|So, Jimmy\|Soong, Richie\|Kono,
PMID:	29034543

97.
Journal:	J Natl Cancer Inst. 2018 Mar 1;110(3):316-320.
Title:	Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Author:	Panda, Anshuman\|Mehnert, Janice M\|Hirshfield, Kim M\|Riedlinger, Greg\|Damare, Sherri\|Saunders, Tracie\|Kane, Michael\|Sokol, Levi\|Stein, Mark N\|Poplin, Elizabeth\|Rodriguez-Rodriguez, Lorna\|Silk, Ann W\|Aisner, Joseph\|Chan, Nancy\|Malhotra, Jyoti\|Frankel, Melis
PMID:	29155997

98.
Journal:	Anticancer Res. 2018 Jan;38(1):107-112.
Title:	Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
Author:	Saito, Hiroaki\|Kono, Yusuke\|Murakami, Yuki\|Shishido, Yuji\|Kuroda, Hirohiko\|Matsunaga, Tomoyuki\|Fukumoto, Yoji\|Osaki, Tomohiro\|Ashida, Keigo\|Fujiwara, Yoshiyuki
PMID:	29277762

99.
Journal:	Cancer Sci. 2018 Mar;109(3):814-820.
Title:	Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.
Author:	Amatatsu, Masahiko\|Arigami, Takaaki\|Uenosono, Yoshikazu\|Yanagita, Shigehiro\|Uchikado, Yasuto\|Kijima, Yuko\|Kurahara, Hiroshi\|Kita, Yoshiaki\|Mori, Shinichiro\|Sasaki, Ken\|Omoto, Itaru\|Maemura, Kosei\|Ishigami, Sumiya\|Natsugoe, Shoji
PMID:	29345842

100.
Journal:	Ann Oncol. 2018 Apr 1;29(4):1030-1036.
Title:	Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
Author:	Kim, S\|Kim, H S\|Kim, E\|Lee, M G\|Shin, E-C\|Paik, S\|Kim, S
PMID:	29360924

101.
Journal:	Oncoimmunology. 2017 Dec 21;7(3):e1356144.
Title:	Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.
Author:	Xing, Xiaofang\|Guo, Jianping\|Wen, Xianzi\|Ding, Guangyu\|Li, Bo\|Dong, Bin\|Feng, Qin\|Li, Shen\|Zhang, Jian\|Cheng, Xiaojing\|Guo, Ting\|Du, Hong\|Hu, Ying\|Wang, Xiaohong\|Li, Lin\|Li, Qingda\|Xie, Meng\|Li, Liting\|Gao, Xiangyu\|Shan, Fei\|Li, Ziyu\|Ying, Xiaomin\|Zhou, T
PMID:	29399387

102.
Journal:	Am J Surg Pathol. 2018 Apr;42(4):453-462.
Title:	Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Author:	Hissong, Erika\|Ramrattan, Girish\|Zhang, Pan\|Zhou, Xi Kathy\|Young, Gloria\|Klimstra, David S\|Shia, Jinru\|Fernandes, Helen\|Yantiss, Rhonda K
PMID:	29438172

103.
Journal:	Biomedicines. 2018 Mar 9;6(1). pii: biomedicines6010032.
Title:	Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.
Author:	Kankeu Fonkoua, Lionel\|Yee, Nelson S
PMID:	29522457

104.
Journal:	J Surg Oncol. 2018 Apr;117(5):829-839.
Title:	Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Author:	Pereira, Marina A\|Ramos, Marcus F K P\|Faraj, Sheila F\|Dias, Andre R\|Yagi, Osmar K\|Zilberstein, Bruno\|Cecconello, Ivan\|Alves, Venancio A F\|de Mello, Evandro S\|Ribeiro, Ulysses Jr
PMID:	29534305

105.
Journal:	Future Oncol. 2018 Apr;14(10):947-962.
Title:	Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.
Author:	Solomon, Benjamin L\|Garrido-Laguna, Ignacio
PMID:	29542354

106.
Journal:	JAMA Oncol. 2018 May 10;4(5):e180013.
Title:	Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Author:	Fuchs, Charles S\|Doi, Toshihiko\|Jang, Raymond W\|Muro, Kei\|Satoh, Taroh\|Machado, Manuela\|Sun, Weijing\|Jalal, Shadia I\|Shah, Manish A\|Metges, Jean-Phillipe\|Garrido, Marcelo\|Golan, Talia\|Mandala, Mario\|Wainberg, Zev A\|Catenacci, Daniel V\|Ohtsu, Atsushi\|Shita
PMID:	29543932

107.
Journal:	Oncotarget. 2018 Jan 6;9(15):12164-12173.
Title:	Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients.
Author:	Wang, Weili\|Wang, Kuansong\|Chen, Zihua\|Chen, Ling\|Guo, Wei\|Liao, Ping\|Rotroff, Daniel\|Knepper, Todd C\|Liu, Zhaoqian\|Zhang, Wei\|Mcleod, Howard L\|He, Yijing
PMID:	29552300

108.
Journal:	Cancers (Basel). 2018 Apr 1;10(4). pii: cancers10040102.
Title:	EBV(+) and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes.
Author:	De Rosa, Simona\|Sahnane, Nora\|Tibiletti, Maria Grazia\|Magnoli, Francesca\|Vanoli, Alessandro\|Sessa, Fausto\|Chiaravalli, Anna Maria
PMID:	29614789

109.
Journal:	Invest New Drugs. 2018 Aug;36(4):726-731.
Title:	Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.
Author:	Nakatani, Yoshihisa\|Kawakami, Hisato\|Ichikawa, Masashi\|Yamamoto, Sachiyo\|Otsuka, Yasuo\|Mashiko, Akiko\|Takashima, Yasutoshi\|Ito, Akihiko\|Nakagawa, Kazuhiko\|Arima, Shuji
PMID:	29623482

110.
Journal:	Gastric Cancer. 2018 Apr 7. pii: 10.1007/s10120-018-0820-3.
Title:	Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
Author:	Cho, Charles J\|Kang, Hyo Jeong\|Ryu, Yeon-Mi\|Park, Young Soo\|Jeong, Hui Jeong\|Park, Young-Mi\|Lim, Hyun\|Lee, Jeong Hoon\|Song, Ho June\|Jung, Hwoon-Yong\|Kim, Sang-Yeob\|Myung, Seung-Jae
PMID:	29627937

111.
Journal:	Cesk Patol. 2018 Spring;54(1):23-26.
Title:	[Predictive diagnostics of gastric cancer in 2018].
Author:	Daum, Ondrej\|Dubova, Magdalena\|Skalova, Alena\|Rozkos, Tomas\|Laco, Jan
PMID:	29631408

112.
Journal:	ESMO Open. 2018 Mar 15;3(3):e000326.
Title:	Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability.
Author:	Cho, Junhun\|Chang, Young Hwan\|Heo, You Jeong\|Kim, Seungtae\|Kim, Nayoung Kd\|Park, Joon Oh\|Kang, Won Ki\|Lee, Jeeyun\|Kim, Kyoung-Mee
PMID:	29636988

113.
Journal:	Cancer Med. 2018 Jun;7(6):2612-2620.
Title:	Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.
Author:	Wang, Lei\|Zhang, Qiongyan\|Ni, Shujuan\|Tan, Cong\|Cai, Xu\|Huang, Dan\|Sheng, Weiqi
PMID:	29673110

114.
Journal:	Oncologist. 2018 Jul;23(7):840-843.
Title:	First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma.
Author:	Chakrabarti, Sakti\|Dong, Haidong\|Paripati, Harshita R\|Ross, Helen J\|Yoon, Harry H
PMID:	29674442

115.
Journal:	BMC Cancer. 2018 Apr 24;18(1):462.
Title:	CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
Author:	Zhang, Chenlu\|Li, Zhi\|Xu, Ling\|Che, Xiaofang\|Wen, Ti\|Fan, Yibo\|Li, Ce\|Wang, Shuo\|Cheng, Yu\|Wang, Xiaoxun\|Qu, Xiujuan\|Liu, Yunpeng
PMID:	29690901

116.
Journal:	Oncol Res Treat. 2018;41(5):272-280.
Title:	Immune Checkpoint Inhibition in Gastro-Oesophageal Cancer.
Author:	Smyth, Elizabeth\|Thuss-Patience, Peter C
PMID:	29705787

117.
Journal:	Tumori. 2018 Mar 1:300891618763215.
Title:	Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.
Author:	Mahjoubi, Linda\|Cecchi, Fabiola\|Massard, Christophe\|Calabro, Fabio\|Gazzah, Anas\|Bahleda, Rastislav\|Jamme, Philippe\|Gelli, Maximiliano\|Goere, Diane\|Lacroix, Ludovic\|Adam, Julien\|Heukamp, Lukas\|Trenta, Patrizia\|Hembrough, Todd\|Soria, Jean-Charles\|Sternberg,
PMID:	29714649

118.
Journal:	Int J Cancer. 2018 Oct 15;143(8):1923-1934.
Title:	Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
Author:	Mizuguchi, Aya\|Takai, Atsushi\|Shimizu, Takahiro\|Matsumoto, Tomonori\|Kumagai, Ken\|Miyamoto, Shin'ichi\|Seno, Hiroshi\|Marusawa, Hiroyuki
PMID:	29717480

119.
Journal:	Ann Surg. 2018 May 1.
Title:	Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Author:	Choi, Yoon Young\|Kim, Hyunki\|Shin, Su-Jin\|Kim, Ha Yan\|Lee, Jinae\|Yang, Han-Kwang\|Kim, Woo Ho\|Kim, Young-Woo\|Kook, Myeong-Cherl\|Park, Young Kyu\|Kim, Hyung-Ho\|Lee, Hye Seung\|Lee, Kyung Hee\|Gu, Mi Jin\|Choi, Seung Ho\|Hong, SoonWon\|Kim, Jong Won\|Hyung, Woo Jin
PMID:	29727332

120.
Journal:	Cancer Treat Rev. 2018 May;66:104-113.
Title:	Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.
Author:	Taieb, Julien\|Moehler, Markus\|Boku, Narikazu\|Ajani, Jaffer A\|Yanez Ruiz, Eduardo\|Ryu, Min-Hee\|Guenther, Silke\|Chand, Vikram\|Bang, Yung-Jue
PMID:	29730461

121.
Journal:	Cancers (Basel). 2018 May 29;10(6). pii: cancers10060167.
Title:	Clinical Importance of Epstein(-)Barr Virus-Associated Gastric Cancer.
Author:	Nishikawa, Jun\|Iizasa, Hisashi\|Yoshiyama, Hironori\|Shimokuri, Kanami\|Kobayashi, Yuki\|Sasaki, Sho\|Nakamura, Munetaka\|Yanai, Hideo\|Sakai, Kohei\|Suehiro, Yutaka\|Yamasaki, Takahiro\|Sakaida, Isao
PMID:	29843478

122.
Journal:	J Immunol Res. 2018 May 8;2018:9485285.
Title:	PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins.
Author:	Tai, Haiyan\|Yang, Qin\|Wu, Zhiyong\|Sun, Su'an\|Cao, Rui\|Xi, Yanfeng\|Zhao, Ran\|Zhang, Mengyu\|Zhang, Zhigang\|Xu, Congjian
PMID:	29854854

123.
Journal:	Biomed Pharmacother. 2018 Jul;103:1688-1700.
Title:	Current and future biomarkers in gastric cancer.
Author:	Abbas, Muhammad\|Faggian, Alessia\|Sintali, Dahiru Nasiru\|Khan, Ghulam Jilany\|Naeem, Shagufta\|Shi, Meiqi\|Dingding, Chen
PMID:	29864959

124.
Journal:	Oncoimmunology. 2018 Feb 20;7(6):e1433520.
Title:	PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers.
Author:	Ying, Le\|Yan, Feng\|Meng, Qiaohong\|Yu, Liang\|Yuan, Xiangliang\|Gantier, Michael P\|Williams, Bryan R G\|Chan, David W\|Shi, Liyun\|Tu, Yugang\|Ni, Peihua\|Wang, Xuefeng\|Chen, Weisan\|Zang, Xingxing\|Xu, Dakang\|Hu, Yiqun
PMID:	29872566

125.
Journal:	Adv Exp Med Biol. 2018;1045:437-457.
Title:	Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Author:	Fukayama, Masashi\|Kunita, Akiko\|Kaneda, Atsushi
PMID:	29896679

126.
Journal:	Gastric Cancer. 2018 Jun 18. pii: 10.1007/s10120-018-0851-9.
Title:	Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
Author:	Sundar, Raghav\|Qamra, Aditi\|Tan, Angie Lay Keng\|Zhang, Shenli\|Ng, Cedric Chuan Young\|Teh, Bin Tean\|Lee, Jeeyun\|Kim, Kyoung-Mee\|Tan, Patrick
PMID:	29915957

127.
Journal:	Mol Cells. 2018 Jul 31;41(7):653-664.
Title:	Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Author:	Guo, Jian\|Qu, Huiheng\|Shan, Ting\|Chen, Yigang\|Chen, Ye\|Xia, Jiazeng
PMID:	29936792

128.
Journal:	Methods Mol Biol. 2018;1817:157-168.
Title:	Mouse-Derived Gastric Organoid and Immune Cell Co-culture for the Study of the Tumor Microenvironment.
Author:	Chakrabarti, Jayati\|Holokai, Loryn\|Syu, LiJyun\|Steele, Nina\|Chang, Julie\|Dlugosz, Andrzej\|Zavros, Yana
PMID:	29959712

129.
Journal:	J Immunol Res. 2018 May 29;2018:4180517.
Title:	PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer.
Author:	Wang, Yangyang\|Zhu, Chunchao\|Song, Wei\|Li, Jun\|Zhao, Gang\|Cao, Hui
PMID:	30003113

130.
Journal:	Ann Gastroenterol Surg. 2018 Jun 5;2(4):313-318.
Title:	Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
Author:	Ito, Masaaki\|Oshima, Yoko\|Yajima, Satoshi\|Suzuki, Takashi\|Nanami, Tatsuki\|Shiratori, Fumiaki\|Funahashi, Kimihiko\|Nemoto, Tetsuo\|Shimada, Hideaki
PMID:	30003194

131.
Journal:	Nat Med. 2018 Sep;24(9):1449-1458.
Title:	Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Author:	Kim, Seung Tae\|Cristescu, Razvan\|Bass, Adam J\|Kim, Kyoung-Mee\|Odegaard, Justin I\|Kim, Kyung\|Liu, Xiao Qiao\|Sher, Xinwei\|Jung, Hun\|Lee, Mijin\|Lee, Sujin\|Park, Se Hoon\|Park, Joon Oh\|Park, Young Suk\|Lim, Ho Yeong\|Lee, Hyuk\|Choi, Mingew\|Talasaz, AmirAli\|Kang,
PMID:	30013197

132.
Journal:	Int J Mol Sci. 2018 Jul 17;19(7). pii: ijms19072079.
Title:	The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
Author:	Gullo, Irene\|Carvalho, Joana\|Martins, Diana\|Lemos, Diana\|Monteiro, Ana Rita\|Ferreira, Marta\|Das, Kakoli\|Tan, Patrick\|Oliveira, Carla\|Carneiro, Fatima\|Oliveira, Patricia
PMID:	30018250

133.
Journal:	Arch Pathol Lab Med. 2018 Jul 20.
Title:	Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer.
Author:	Kulangara, Karina\|Zhang, Nancy\|Corigliano, Ellie\|Guerrero, Lindsay\|Waldroup, Stephanie\|Jaiswal, Dipeshkumar\|Ms, Malinka Jansson\|Shah, Supriya\|Hanks, Debra\|Wang, Jiangdian\|Lunceford, Jared\|Savage, Mary J\|Juco, Jonathan\|Emancipator, Kenneth
PMID:	30028179

134.
Journal:	EXCLI J. 2018 Jun 6;17:526-530.
Title:	Avelumab inducing hypothyroidism and hypoadrenalism: A case report and review of literature.
Author:	Aziz, Kashif\|Shahbaz, Amir\|Umair, Muhammad\|Sachmechi, Isaac
PMID:	30034316

135.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2018 Aug 8;47(8):597-602.
Title:	[Relationship between PD-L1 protein expression and gene amplification in gastric cancer tissues].
Author:	Liu, Y\|Wang, J F\|Li, X W\|Bu, P\|Bai, W\|Li, L M
PMID:	30107664

136.
Journal:	Oncologist. 2018 Aug 17. pii: theoncologist.2018-0221.
Title:	FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.
Author:	Fashoyin-Aje, Lola\|Donoghue, Martha\|Chen, Huanyu\|He, Kun\|Veeraraghavan, Janaki\|Goldberg, Kirsten B\|Keegan, Patricia\|McKee, Amy E\|Pazdur, Richard
PMID:	30120163

137.
Journal:	J Cell Biochem. 2018 Aug 26.
Title:	LPS promotes the expression of PD-L1 in gastric cancer cells through NF-kappaB activation.
Author:	Li, Hui\|Xia, Jun-Quan\|Zhu, Fang-Shi\|Xi, Zhao-Hong\|Pan, Cheng-Yu\|Gu, Li-Mei\|Tian, Yao-Zhou
PMID:	30145830

138.
Journal:	Clin Exp Pharmacol Physiol. 2018 Aug 30.
Title:	The roles of PD-1/PD-L1 and its signalling pathway in gastrointestinal tract cancers.
Author:	Cui, Chunguo\|Yu, Bo\|Jiang, Qi\|Li, Xingfang\|Shi, Kaiyao\|Yang, Zecheng
PMID:	30161295

139.
Journal:	Cell Mol Life Sci. 2018 Sep 1. pii: 10.1007/s00018-018-2906-9.
Title:	Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.
Author:	Ratti, Margherita\|Lampis, Andrea\|Hahne, Jens C\|Passalacqua, Rodolfo\|Valeri, Nicola
PMID:	30173350

140.
Journal:	Crit Rev Oncol Hematol. 2018 Oct;130:13-26.
Title:	Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists.
Author:	Stein, Alexander\|Markus, Moehler\|Jorg, Trojan\|Eray, Goekkurt\|Vogel, Arndt
PMID:	30196908

141.
Journal:	Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6739-4.
Title:	Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.
Author:	Ito, Shuhei\|Fukagawa, Takeo\|Noda, Miwa\|Hu, Qingjiang\|Nambara, Sho\|Shimizu, Dai\|Kuroda, Yosuke\|Eguchi, Hidetoshi\|Masuda, Takaaki\|Sato, Tetsuya\|Katai, Hitoshi\|Sasako, Mitsuru\|Mimori, Koshi
PMID:	30203407

142.
Journal:	Cell Death Dis. 2018 Sep 11;9(9):928.
Title:	Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.
Author:	Sun, Li\|Wang, Qianqian\|Chen, Bin\|Zhao, Yuanyuan\|Shen, Bo\|Wang, Hua\|Xu, Jing\|Zhu, Miaolin\|Zhao, Xiangdong\|Xu, Changgen\|Chen, Zhihong\|Wang, Mei\|Xu, Wenrong\|Zhu, Wei
PMID:	30206229

143.
Journal:	Oncoimmunology. 2018 Apr 24;7(8):e1457602.
Title:	The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression.
Author:	Buglioni, Simonetta\|Melucci, Elisa\|Sperati, Francesca\|Pallocca, Matteo\|Terrenato, Irene\|De Nicola, Francesca\|Goeman, Frauke\|Casini, Beatrice\|Amoreo, Carla Azzurra\|Gallo, Enzo\|Diodoro, Maria Grazia\|Pescarmona, Edoardo\|Vici, Patrizia\|Sergi, Domenico\|Pizzuti
PMID:	30221053

144.
Journal:	Sci Rep. 2018 Sep 17;8(1):13887.
Title:	Computational measurement of tumor immune microenvironment in gastric adenocarcinomas.
Author:	Chang, Young Hwan\|Heo, You Jeong\|Cho, Junhun\|Song, Sang Yong\|Lee, Jeeyun\|Kim, Kyoung-Mee
PMID:	30224753

145.
Journal:	Am Soc Clin Oncol Educ Book. 2018 May 23;(38):249-261.
Title:	What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
Author:	De Mello, Ramon Andrade\|Castelo-Branco, Luis\|Castelo-Branco, Pedro\|Pozza, Daniel Humberto\|Vermeulen, Louis\|Palacio, Sofia\|Salzberg, Matthew\|Lockhart, A Craig
PMID:	30231398

146.
Journal:	Genes Chromosomes Cancer. 2018 Sep 21.
Title:	Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
Author:	Koh, Jiwon\|Nam, Soo Kyung\|Roh, Hanseong\|Kim, Jonghyuk\|Lee, Byung-Chul\|Kim, Jin Won\|Ahn, Sang-Hoon\|Park, Do Joong\|Kim, Hyung-Ho\|Park, Kyoung Un\|Chung, Jin Haeng\|Kim, Woo Ho\|Lee, Hye Seung
PMID:	30239046

147.
Journal:	Gastric Cancer. 2018 Sep 28. pii: 10.1007/s10120-018-0880-4.
Title:	EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions.
Author:	Sasaki, Sho\|Nishikawa, Jun\|Sakai, Kohei\|Iizasa, Hisashi\|Yoshiyama, Hironori\|Yanagihara, Masashi\|Shuto, Takuya\|Shimokuri, Kanami\|Kanda, Teru\|Suehiro, Yutaka\|Yamasaki, Takahiro\|Sakaida, Isao
PMID:	30264329

148.
Journal:	Anticancer Res. 2018 Oct;38(10):5569-5580.
Title:	Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
Author:	Park, Robin\|Williamson, Stephen\|Kasi, Anup\|Saeed, Anwaar
PMID:	30275174

149.
Journal:	Cancer Res Treat. 2018 Sep 27. pii: crt.2018.331.
Title:	Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial.
Author:	Kim, Min Hwan\|Zhang, Xianglan\|Jung, Minkyu\|Jung, Inkyung\|Park, Hyung Soon\|Beom, Seung-Hoon\|Kim, Hyo Song\|Rha, Sun Young\|Kim, Hyunki\|Choi, Yoon Young\|Son, Taeil\|Kim, Hyoung-Il\|Cheong, Jae-Ho\|Hyung, Woo Jin\|Noh, Sung Hoon\|Chung, Hyun Cheol
PMID:	30282452

150.
Journal:	J Immunother Cancer. 2018 Oct 11;6(1):106.
Title:	Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment.
Author:	Tada, Yasuko\|Togashi, Yosuke\|Kotani, Daisuke\|Kuwata, Takeshi\|Sato, Eichi\|Kawazoe, Akihito\|Doi, Toshihiko\|Wada, Hisashi\|Nishikawa, Hiroyoshi\|Shitara, Kohei
PMID:	30314524

151.
Journal:	Onco Targets Ther. 2018 Oct 4;11:6525-6537.
Title:	Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy.
Author:	Mehta, Rutika\|Shah, Anand\|Almhanna, Khaldoun
PMID:	30323626

152.
Journal:	Exp Cell Res. 2018 Oct 24. pii: S0014-4827(18)31118-2.
Title:	MiR-940 Promotes the Proliferation and Migration of Gastric Cancer Cells through Up-regulation of Programmed Death Ligand-1 Expression.
Author:	Fan, Yibo\|Che, Xiaofang\|Hou, Kezuo\|Zhang, Min\|Wen, Ti\|Qu, Xiujuan\|Liu, Yunpeng
PMID:	30367831

153.
Journal:	Future Oncol. 2018 Oct 31.
Title:	Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.
Author:	Moehler, Markus\|Ryu, Min-Hee\|Dvorkin, Mikhail\|Lee, Keun-Wook\|Coskun, Hasan S\|Wong, Rachel\|Chung, Hyun C\|Poltoratsky, Artem\|Tsuji, Akihito\|Yen, Chia Jui\|Muntean, Alina S\|Sourd, Samuel Le\|Vaccaro, Gina M\|Overton, Lindsay\|Boku, Narikazu\|Wainberg, Zev A\|Patel
PMID:	30379568